Clinical Trial Update: Hetrombopag or Placebo in Treatment-Naive Severe Aplastic Anemia [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating hetrombopag versus placebo in treatment-naive severe aplastic anemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• Hetrombopag (hetrombopag)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Severe Aplastic Anemia | Phase 3 | Status: COMPLETED